A study for a 30 year old woman who takes Depakote - from FDA reports


2,345 females aged 30 (±5) who take the same drug are studied. This is a personalized study for a 30 year old female patient who has Bipolar Affective Disorder. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Aug, 21, 2018

2,345 females aged 30 (±5) who take Depakote are studied.


Number of reports submitted per year:

Depakote for a 30-year old woman.

Information of the patient in this study:

  • Age: 30
  • Gender: female
  • Conditions: Bipolar Affective Disorder
  • Drugs taken:
    • Depakote (divalproex sodium)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Reduced Appetite: 16 (0.68% of females aged 30 (±5) who take the drug)
  • Abdominal Pain: 72 (3.07% of females aged 30 (±5) who take the drug)
  • Nausea And Vomiting: 83 (3.54% of females aged 30 (±5) who take the drug)
  • Fatigue(feeling of tiredness): 112 (4.78% of females aged 30 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  1. Nausea (feeling of having an urge to vomit)
  2. Nausea and vomiting
  3. Breathing difficulty
  4. Drug level above therapeutic
  5. Alanine aminotransferase increased
1 - 6 months:
  1. Nausea (feeling of having an urge to vomit)
  2. Weight increased
  3. Abdominal pain
  4. Fever
  5. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
6 - 12 months:
  1. Weight increased
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Drug ineffective
  5. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
1 - 2 years:
  1. Type 2 diabetes
  2. Muscle aches (muscle pain)
  3. Fatigue (feeling of tiredness)
  4. Joint pain
  5. Constipation
2 - 5 years:
  1. Type 2 diabetes
  2. High blood cholesterol
  3. Stress and anxiety
  4. Hyperlipidaemia (presence of excess lipids in the blood)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
5 - 10 years:
  1. Type 2 diabetes
  2. Coronary heart disease (narrowing or blockage of the coronary arteries)
  3. High blood pressure
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Cardiomyopathy (weakening of the heart muscle)
10+ years:
  1. Memory loss
  2. Weight increased
  3. Abnormal loss of weight
  4. Abnormal dreams
  5. Scurvy (a disease caused by deficiency of vitamin c, characterized by spongy and bleeding gums, bleeding under the skin, and extreme weakness)
not specified:
  1. Weight increased
  2. Nausea (feeling of having an urge to vomit)
  3. Diabetes
  4. Fatigue (feeling of tiredness)
  5. Type 2 diabetes

Top conditions involved for these people *:

  1. Depression : 208 people, 8.87%
  2. Stress And Anxiety : 135 people, 5.76%
  3. Pain : 101 people, 4.31%
  4. Birth Control : 96 people, 4.09%
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 89 people, 3.80%

Top co-used drugs for these people *:

  1. Seroquel (396 people, 16.89%)
  2. Zyprexa (284 people, 12.11%)
  3. Risperdal (268 people, 11.43%)
  4. Klonopin (225 people, 9.59%)
  5. Abilify (185 people, 7.89%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

Related publications that referenced our studies

Recent updates

General studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.